title: When do we judge IVIg for myasthenia gravis ineffective?
authors.affiliation: Department of Neurology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan, tsubasa.takizawa@z5.keio.jp.
authors.forename: Tsubasa
authors.initials: T
authors.lastname: Takizawa
authors.forename: Shigeaki
authors.initials: S
authors.lastname: Suzuki
authors.forename: Norihiro
authors.initials: N
authors.lastname: Suzuki
mesh_terms: D005260:Female; D006801:Humans; D007116:Immunization, Passive; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D008297:Male; D009157:Myasthenia Gravis / Q000188:drug therapy*
chemical_list: D016756:Immunoglobulins, Intravenous